Ayhan-Kilcigil Gulgun, Kuş Canan, Çoban Tülay, Özdamar Elcin D, Can-Eke Benay
Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Ankara University, Ankara, Turkey.
Arch Pharm (Weinheim). 2014 Apr;347(4):276-82. doi: 10.1002/ardp.201300324. Epub 2014 Jan 9.
In this study, some novel 5-[[2-(phenyl/p-chlorophenyl)-benzimidazol-1-yl]-methyl]-N-substituted phenyl-1,3,4-oxadiazol-2-amine derivatives (28-45) with an oxadiazole ring were synthesized. The antioxidant properties and radical scavenging activities of the compounds were investigated employing various in vitro systems: hepatic microsomal NADPH-dependent inhibition of lipid peroxidation levels, scavenging of DPPH free radicals, and inhibition of microsomal ethoxyresorufin O-deethylase activity (EROD). Compounds 34 and 41 were found to be good scavengers of DPPH radicals (76% and 84%) when compared to BHT (90%). Almost all of the compounds examined were found to possess a good inhibitor effect on the microsomal EROD activity. Moreover, 32 and 41 were more active analogs (97% and 98%) on the microsomal EROD activity than caffeine (85%).
在本研究中,合成了一些带有恶二唑环的新型5-[[2-(苯基/对氯苯基)-苯并咪唑-1-基]-甲基]-N-取代苯基-1,3,4-恶二唑-2-胺衍生物(28 - 45)。采用各种体外系统研究了这些化合物的抗氧化性能和自由基清除活性:肝微粒体中NADPH依赖的脂质过氧化水平抑制、DPPH自由基清除以及微粒体乙氧基异吩恶唑酮O-脱乙基酶活性(EROD)抑制。与丁基羟基甲苯(BHT,90%)相比,化合物34和41被发现是良好的DPPH自由基清除剂(76%和84%)。几乎所有检测的化合物都被发现对微粒体EROD活性具有良好的抑制作用。此外,化合物32和41对微粒体EROD活性的抑制作用比咖啡因(85%)更强(分别为97%和98%)。